Relationship of Post-Transplant Lymphoproliferative Disorders (PTLD) Subtypes and Clinical Outcome in Pediatric Heart Transplant Recipients: A Retrospective Single Institutional Analysis/Experience of 558 Patients
Open Access
Abstract
Post-transplant lymphoproliferative disorders (PTLD) are heterogenous lymphoproliferative disorders that develop as a consequence of immunosuppression in transplant recipients. We sought to determine if subtypes of PTLD correlated with different outcomes. We performed a retrospective review of PTLD occurring in pediatric heart transplant recipients. A total of 558 children and infants underwent cardiac transplantation at our institution between 1985 and 2019 and were followed until March 2021. Forty-nine of 558 patients developed PTLD (8.8%). As compared to older children (>one year of age), infant recipients (p = 0.04). Although not reaching statistical significance, patients with a shorter time to PTLD diagnosis showed a trend toward higher rates of M-PTLD or cHL. As expected, the overall survival (OS) of patients with M-PTLD or cHL was significantly lower than patients with non-destructive or polymorphic PTLD.Keywords
This publication has 32 references indexed in Scilit:
- Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment StrategiesCurrent Hematologic Malignancy Reports, 2013
- Early Posttransplant Lymphoproliferative DiseaseAmerican Journal of Clinical Pathology, 2012
- Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★American Journal of Transplantation, 2011
- Origins of Neonatal Heart Transplantation: An Historical PerspectiveSeminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual, 2011
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- Post-transplant lymphoproliferative disorder in pediatric heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2010
- Risk Factors for Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients With Cytomegalovirus AntigenemiaTransplantation Proceedings, 2010
- Diagnosis and treatment of post‐transplantation lymphoproliferative disorder in pediatric heart transplant patientsPediatric Transplantation, 2009
- Lymphomas occurring late after solid-organ transplantationTransplantation, 2002
- CLASSIFICATION OF EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASES: Implications for Understanding their Pathogenesis and Developing Rational Treatment StrategiesAnnual Review of Medicine, 1995